# Safety and Efficacy of PBK-1701TC for Bowel Cleansing Before Colonoscopy

> **NCT03509220** · PHASE3 · COMPLETED · sponsor: **Pharmbio Korea Co., Ltd.** · enrollment: 235 (actual)

## Conditions studied

- Colonic Diseases
- Intestinal Disease
- Gastrointestinal Disease
- Digestive System Disease

## Interventions

- **DRUG:** PBK-1701TC
- **DRUG:** Standard oral preparation

## Key facts

- **NCT ID:** NCT03509220
- **Lead sponsor:** Pharmbio Korea Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-04-11
- **Primary completion:** 2018-10-31
- **Final completion:** 2018-10-31
- **Target enrollment:** 235 (ACTUAL)
- **Last updated:** 2018-11-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03509220

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03509220, "Safety and Efficacy of PBK-1701TC for Bowel Cleansing Before Colonoscopy". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03509220. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*